The global cell processing market size is expected to increase, owing to rising demand for cell therapy. Cell therapy is the only curative treatment for many diseases such as cancer, autoimmune disease, and neural disease. According to the Worldwide Network for Blood and Marrow Transplantation (WBMT), in 2012, around one million stem cell transplantations were performed, worldwide.
Continuous research and development for new innovative techniques for cell isolation, concentration, and preservation is another major factor driving the cell processing market size. According to University of California, Los Angeles (UCLA) 2016 research report, researchers have developed a new magnetic ratcheting system to separate and organize cells suspended in fluid samples by their subtle biochemical differences. The system sorts cells more quickly and accurately and perform simple, rapid automation of cell analysis and can separate therapeutic cells from non-therapeutic cells.
Global Cell Processing Market: Restraints
The major restraining factors affecting the cell processing market revenue includes safety issues for patients, commercialization of cells. It also includes safety issues for preservation and distribution of cells or customized cell therapies for patients. Failures of stem cell therapy trials due to stringent rules and regulations also hamper the cell processing market growth. For instance, in 2014, a U.S.-based company Athersys Inc. along with Pfizer conducted a clinical trial on stem cell product Multistem infusion in patients with ulcerative colitis. The trial failed to meet efficacy end points from the FDA in interim analysis.
Cell Processing Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients